CDKN2A and neoplasm: The necessity of p16 activity in HPV-transformed cells specifies the utility of this tumor suppressor protein as an essential biomarker for the diagnosis of HPV + OPSCC, as the expression is much less similar to being lost or downregulated than that of a protein with deleterious or neutral effects on tumor cell fitness.